Günther Weindl
Professor
Department of pharmacy
Federal Institute for Risk Assessment
Germany
Biography
2016 - 2017 Representation of the Chair of Pharmacology and Toxicology (W2), Pharmaceutical Institute, Rheinische Friedrich-Wilhelms-Universität Bonn since 2011 Professor of Pharmacology (W1), Institute of Pharmacy (Pharmacology and Toxicology), Freie Universität Berlin 2007 - 2011 Scientific assistant with Prof. Dr. Monika Schäfer-Korting, Institute of Pharmacy (Pharmacology and Toxicology), Freie Universität Berlin 2005 - 2007 Scientific assistant with Prof. Dr. Martin Schaller, University Skin Clinic, Eberhard-Karls-Universität Tübingen.
Research Interest
Receptor-mediated regulation of inflammatory processe,s immune Pharmacology and Reconstructed tissue models as alternative test systems.
Publications
-
(1998) Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues. Arch Toxicol. DOI: 10.1007 / s00204-017-1954-5
-
Su Q, Palatingraff A, Weindl G (2017) Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signaling. J Steroid Biochem Mol Biol. DOI: 10.1016 / j.jsbmb.2017.03.023
-
Palatinate A, Heinbockel L, Su Q, Brandenburg K, Weindl G (2017) Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses. Biochem Pharmacol. DOI: 10.1016 / j.bcp.2017.05.015
